Is extended 11-core biopsy valuable in benign prostatic hyperplasia patients with intermediate serum prostate-specific antigen (4.1-10 ng/ml) and prior negative sextant biopsy?

By Abdel-khalek Mohamed   El-Baz Mahmoud   Ibrahiem El-Houssieny  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 4, 2004-09 ,pp. : 315-320

Informa Healthcare

Access to resources Recommend Favorite

''BPSA,'' a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia1

By Mikolajczyk S.D.   Millar L.S.   Wang T.J.   Rittenhouse H.G.   Wolfert R.L.   Marks L.S.   Song W.   Wheeler T.M.   Slawin K.M.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 41-45

Elsevier

Access to resources Recommend Favorite

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study

By Kaplan S.A.   Ghafar M.A.   Volpe M.A.   Lam J.S.   Fromer D.   Te A.E.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 464-468

Elsevier

Access to resources Recommend Favorite

Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia - the establishment of appropriate reference ranges for concentrations and ratios

By Cetinkaya M.   Ulusoy E.   Aki T.   Kosan M.   Kundak c.   Aydos M.M.   Gokkaya S.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 118-120

Elsevier

Access to resources Recommend Favorite

Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia

By Mochtar C.A.   Kiemeney L.A.L.M.   van Riemsdijk M.M.   Barnett G.S.   Laguna M.P.   Debruyne F.M.J.   de la Rosette J.J.M.C.H.  

European Urology, Vol. 44, Iss. 6, 2003-12 ,pp. : 695-700

Elsevier

Access to resources Recommend Favorite